Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The substantial gap between preclinical evidence and clinical validation represents the primary limitation for evidence-based clinical use
Those studies support the broader repair mechanism
In those cases, BPC-157 may support surrounding soft tissue in some patients, but it should not be framed as a treatment that reverses the underlying structural problem
A severe tendon tear, fracture, infection, nerve compression, progressive weakness, unexplained swelling, or rapidly worsening pain needs appropriate evaluation
Not for human consumption, therapeutic use or clinical applications
US$ 26.80
US$ 21.39
US$ 25.25
